ArQule, Inc. (ARQL) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
ArQule, Inc. (ARQL)

An SI Board Since April 2003

Posts	SubjectMarks	Bans	Symbol
545	40	0	ARQL

Emcee: tuck	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
45	Ask and you shall receive. 10/23/03 end of day purchased 8000 shares ArQule (AR	tom pope	-	10/24/2003
44	According to a poster on Yahoo!, Ron Garren's InvestBio has added ARQL. Any	tuck	-	10/24/2003
43	Q3 2003 ArQule, Inc. Earnings Conference Call Boston, Oct 23, 2003 (CCBN Street	mopgcw	-	10/24/2003
42	I have been waiting for this opportunity. Hoping for $4 even, but I could be to	mopgcw	-	10/23/2003
41	SLight clarification on listening to that portion of the CC again . . . week	tuck	-	10/23/2003
40	I bought a few hundred at $4.55 today, but I haave a guess as to what spooked th	tuck	-	10/23/2003
39	Yes, it does seem strange. Maybe there was something in the CC that the market d	tom pope	-	10/23/2003
38	ARQL reports, raises 03 guidance slightly, but stock is off almost 10%. Not sur	tuck	-	10/23/2003
37	[New screening system to address the M in ADME-Tox] >>J Biomol Screen. 20	tuck	-	10/22/2003
36	ArQule to Present at MASS Opportunities Biotechnology Investment 2003-10-21 16:3	mopgcw	-	10/21/2003
35	ArQule to Present at Rodman & Renshaw Techvest Healthcare Conference on Tues	mopgcw	-	10/15/2003
34	good idea. Thanks!	mopgcw	-	10/15/2003
33	Maybe volume spikes will give an earlier warning? Cheers, Tuck	tuck	-	10/15/2003
32	Tuck, Not too late at the moment, It was a reference to WE's comment..Too l	mopgcw	-	10/2/2003
31	>>Then it is too late, I think?? << If CO-501 shows anti-tumor acti	keokalani'nui	-	10/2/2003
30	George, They just started dosing; how could it be too late? Cheers, Tuck	tuck	-	10/2/2003
29	<b> Watch the stock price for the results. </b> Then it is too late	mopgcw	-	10/1/2003
28	With that message I should have also noted that orbimed implemented a rebalancin	keokalani'nui	-	10/1/2003
27	I guess they do not like the burn associated with the transition? the stock se	mopgcw	-	10/1/2003
26	ArQule Initiates First Human Clinical Trial With CO-501 WOBURN, Mass., Sept. 30	nigel bates	-	9/30/2003
25	Orbimed continues to lighten up on arql. Still hold 4%+.	keokalani'nui	-	9/29/2003
24	Arqule Completes Acquisition of Cyclis Pharmaceuticals Acquisition provides near	mopgcw	-	9/8/2003
23	HI, now I'm back. Greeeaat vacation, but good to be home. Here's some	tuck	-	8/19/2003
22	A reminder to look for the lock-up when cyclis documents are filed. There ought	keokalani'nui	-	8/13/2003
21	>> I was surprised to find that there is no thread for ArQule. Perhaps the	scaram(o)uche	-	8/13/2003

Go to reply# or date (mm/dd/yy):